Over the last decade, genetic testing in the form of chromosomal microarray analysis (CMA) and next-generation sequencing (NGS) panels have become routine diagnostic investigations for many health ...

“Adding Toxikon underscores our commitment to nonclinical development and advances our capabilities for both drug development and medical device testing,” said Dr. Paul Kirchgraber, CEO of Labcorp ...

MESA, AZ / ACCESS Newswire / June 12, 2026 / Medical Care Technologies, Inc. (OTC PINK:MDCE) (“MDCE” or the “Company”), a ...